Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$448.94 USD
-17.48 (-3.75%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $449.18 +0.24 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TMO 448.94 -17.48(-3.75%)
Will TMO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TMO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMO
Investing in Thermo Fisher (TMO)? Don't Miss Assessing Its International Revenue Trends
Beat the Market the Zacks Way: Oracle, Credo Tech, Palantir in Focus
TMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
ISRG's Gross Margin Falls on Product Transition and Trade Pressures
Other News for TMO
Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets
Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q2 2025 Update
Bio-Techne: Coveted Life Sciences Asset On Sale Due To Academic Pressures
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
Janus Henderson Balanced Fund Q2 2025 Commentary